Document Detail

Vancomycin use in pediatric neurosurgery patients.
MedLine Citation:
PMID:  10586151     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The objective of this article is to describe a pediatric neurosurgery patient population receiving vancomycin and examine the indications for and appropriateness of vancomycin use. METHODS: A cross-sectional study was performed on the pediatric neurosurgery patients at Egleston Children's Hospital who received vancomycin from January 1 through December 31, 1996. Vancomycin use was compared with the Centers for Disease Control and Prevention Hospital Infection Control Practices Advisory Committee recommendations for vancomycin use. RESULTS: Thirty patients received 115 doses of vancomycin. The median patient age was 8.0 years, and 17 (56.7%) were male. Vancomycin was used for prophylaxis in 28 (93.3%) patients and empiric therapy in 3 (10.0%) patients; one patient received vancomycin for surgical prophylaxis followed by empiric therapy for suspected meningitis. Vancomycin prophylaxis was initiated after the incision in 6 (21.4%) patients and was continued as prophylaxis for more than one dose in 26 (92.9%) patients. CONCLUSIONS: Vancomycin was used primarily as surgical prophylaxis in pediatric neurosurgery patients, and use was not consistent with the Hospital Infection Control Practices Advisory Committee recommendations. These data suggest that for certain subpopulations, such as pediatric neurosurgery patients, there is a need for more specialized recommendations. Furthermore, prudent vancomycin use is warranted to successfully decrease the risk of further emergence of vancomycin resistance. Because vancomycin use may be prevalent in this population, assessment of vancomycin use in pediatric neurosurgery patients followed by establishment of vancomycin clinical guidelines may help improve the appropriateness of vancomycin use in this population.
S S Shah; R L Sinkowitz-Cochran; H L Keyserling; W R Jarvis
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of infection control     Volume:  27     ISSN:  0196-6553     ISO Abbreviation:  Am J Infect Control     Publication Date:  1999 Dec 
Date Detail:
Created Date:  2000-01-24     Completed Date:  2000-01-24     Revised Date:  2009-08-14    
Medline Journal Info:
Nlm Unique ID:  8004854     Medline TA:  Am J Infect Control     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  482-7     Citation Subset:  IM    
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use*
Antibiotic Prophylaxis*
Child, Preschool
Cross-Sectional Studies
Drug Utilization / statistics & numerical data
Hospital Departments / statistics & numerical data
Neurosurgical Procedures / methods
Postoperative Complications / drug therapy*
Reproducibility of Results
Sampling Studies
United States
Vancomycin / therapeutic use*
Vancomycin Resistance*
Reg. No./Substance:
0/Anti-Bacterial Agents; 1404-90-6/Vancomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Methodologies used in surveillance of surgical wound infections and bacteremia in Australian hospita...
Next Document:  A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dres...